In a move to bolster its line of genetic tests for detecting myriad cancers, Abbott Laboratories Wednesday said it agreed to acquire upstart Downers Grove-based biotech company Vysis Inc. for $355 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results